Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 3Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

NETWORK 5OTHER 4NIH 3INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 2Head & Neck 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Neuroblastoma 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Fenretinide × Clear all
NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed
17 enrolled
CNS

Neuroblastoma

NCT00102635 2018-11-15

4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 1 Terminated
1 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00003250 2014-04-11

Fenretinide in Treating Patients With Solid Tumors

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
31 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005819 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Case Comprehensive Cancer Center

Phase 1 Completed
21 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡